Congress trades

HealthEquity, Inc. (HQY)

NASDAQ · Healthcare · 23 congress trades · last filed 7 days ago

20
Congress disclosures shown
39d
Median delay on the congress disclosures
of the 45 day limit
12/8
Purchases and sales in the disclosures shown

About HealthEquity, Inc.

from the company's filings and listing
Exchange
NASDAQ
Sector
Healthcare
Industry
Medical - Healthcare Information Services
Chief executive
Scott R. Cutler
Employees
2,814
Listed since
-
Market value
$7.7B
Price to earnings
33.1
Earnings per share
$2.84
Dividend yield
-

www.healthequity.com

Earnings

6 reported quarters · next on Dec 2, 2026
QuarterEPSEPS expectedRevenueRevenue expectedResult
Q2 FY2027reported Aug 27, 2026$1.24$1.19$350.7M$349.2MEPS beatRevenue in line
Q1 FY2027reported May 28, 2026$1.24$1.11$354.6M$352.0MEPS beatRevenue in line
Q4 FY2026reported Mar 17, 2026$0.95$0.89$334.6M$332.3MEPS beatRevenue in line
Q3 FY2026reported Dec 3, 2025$1.01$0.91$322.2M$320.6MEPS beatRevenue in line
Q2 FY2026reported Sep 2, 2025$1.08$0.91$325.8M$320.7MEPS beatRevenue beat
Q1 FY2026reported Jun 3, 2025$0.97$0.81$330.8M$322.3MEPS beatRevenue beat

Actual against the consensus estimate at the time. A flag marks a beat or a miss of more than 1.5% either way; inside that band the quarter is in line. A flag marked GAAP compares a GAAP figure the company reported with an adjusted consensus, two different measures, so a one-time gain or charge can move it either way; basis unverified means we could not classify the reported figure. A flag reads n/a only when a number is missing. An estimate is a forecast made by analysts, not a company target.

Executive pay

as filed for 2026 · proxy filed May 13, 2026
ExecutiveSalaryStock awardsOtherTotal
Scott CutlerPresident and Chief Executive Officer$775K$12.0M$769K$13.6M
James LucaniaExecutive Vice President and Chief Financial Officer$575K$4.1M$487K$5.2M
Michael FioreExecutive Vice President and Chief Commercial Officer$550K$3.2M$413K$4.2M
Delano LaddExecutive Vice President and General Counsel$400K$2.9M$310K$3.6M
Stephen Neeleman, M.D.Founder and Vice Chairman$492K$2.6M$369K$3.5M

The summary compensation table from the 2026 proxy statement, current executives only. 1 executive who has since left the company is named in that filing and not shown here. Read the filing

Institutional holders

13F positions as of Jun 30, 2026
HolderValueSharesChangeOf company
Blackrock, Inc.$1.0B11,277,914+7.1%13.53%
Wasatch Advisors LP$719.0M7,960,735+10.5%9.55%
Morgan Stanley$410.7M4,547,219+82.9%5.45%
Vanguard Portfolio Management LLC$366.5M4,057,643-2.5%4.87%
Vanguard Capital Management LLC$328.8M3,640,776-4.8%4.37%
State Street Corp$292.7M3,241,046+4.6%3.89%
Geode Capital Management, LLC$214.5M2,374,467+5.1%2.85%
AQR Capital Management LLC$176.1M1,999,209-4.4%2.40%
Dimensional Fund Advisors LP$168.8M1,869,036+14.9%2.24%
William Blair Investment Management, LLC$160.2M1,773,227+6.8%2.13%
FMR LLC$138.9M1,538,387+35.5%1.85%
Brown Advisory Inc$124.0M1,372,624-2.8%1.65%

A 13F reports long US equity positions 45 days after the quarter ends, so these are positions as they stood on Jun 30, 2026. For a manager's whole book see the fund directory.

Know the moment the next HQY filing lands.

GetSignal watches Form 4 and STOCK Act filings and pushes each one to your phone as it is published, with the history behind it. Free on iOS and Android.

Congress trades in HQY

20 disclosures of 23 on record · median 39d of the 45 allowed
MemberTypeActionAmount disclosedSince the tradeTrade dateDisclosedDelay
Gilbert Ray Cisneros, Jr.Filed lateStockPurchase$1,001 - $15,000-1.8%S&P +1.0% · vs S&P 500 -2.8%Jul 10, 2026Sep 4, 202656d
Gilbert Ray Cisneros, Jr.StockPurchase$1,001 - $15,000+2.6%S&P +2.1% · vs S&P 500 +0.5%Jun 30, 2026Jul 2, 20262d
Gilbert Ray Cisneros, Jr.StockPurchase$1,001 - $15,000+5.3%S&P +0.8% · vs S&P 500 +4.5%May 29, 2026Jun 8, 202610d
Lisa C. McClainSpouseFiled lateStockSale$1,001 - $15,000-6.2%S&P +27.8% · vs S&P 500 -34.0%Jun 17, 2025Aug 13, 202557d
Lisa C. McClainSpouseFiled lateStockPurchase$1,001 - $15,000-10.3%S&P +27.0% · vs S&P 500 -37.3%Jun 11, 2025Aug 13, 202563d
Gilbert Ray Cisneros, Jr.StockSale$1,001 - $15,000-8.3%S&P +26.5% · vs S&P 500 -34.8%Jun 16, 2025Jul 10, 202524d
Robert BresnahanJointStockSale$1,001 - $15,000-9.0%S&P +31.1% · vs S&P 500 -40.1%Jan 13, 2025Feb 13, 202531d
Josh GottheimerJointStockSale$1,001 - $15,000-4.7%S&P +28.0% · vs S&P 500 -32.7%Nov 7, 2024Dec 5, 202428d
Josh GottheimerJointStockSale$1,001 - $15,000+10.8%S&P +39.7% · vs S&P 500 -28.9%Jun 21, 2024Jul 9, 202418d
Blake D. MooreStockSale$1,001 - $15,000+26.7%S&P +58.1% · vs S&P 500 -31.4%Jan 19, 2024Jan 24, 20245d
Daniel S. GoldmanStockSale$15,001 - $50,000+60.8%S&P +86.2% · vs S&P 500 -25.4%Apr 10, 2023May 19, 202339d
Josh GottheimerJointStockPurchase$1,001 - $15,000+87.1%S&P +63.7% · vs S&P 500 +23.4%Jan 10, 2022Feb 18, 202239d
Josh GottheimerJointStockSale$1,001 - $15,000+120.3%S&P +63.5% · vs S&P 500 +56.8%Dec 9, 2021Jan 10, 202232d
Blake D. MooreFiled lateStockPurchase$1,001 - $15,000+27.4%S&P +88.3% · vs S&P 500 -61.0%May 12, 2021Jul 17, 202166d
Blake D. MooreFiled lateStockPurchase$1,001 - $15,000+34.0%S&P +92.9% · vs S&P 500 -58.9%Mar 26, 2021Jul 17, 2021113d
Blake D. MooreFiled lateStockPurchase$1,001 - $15,000+30.0%S&P +84.3% · vs S&P 500 -54.3%May 11, 2021Jul 17, 202167d
Blake D. MooreFiled lateStockPurchase$1,001 - $15,000+23.4%S&P +83.0% · vs S&P 500 -59.6%Apr 30, 2021Jul 17, 202178d
Gilbert Ray Cisneros, Jr.StockPurchase$1,001 - $15,000+59.0%S&P +137.1% · vs S&P 500 -78.1%Jul 17, 2020Aug 19, 202033d
Josh GottheimerJointStockPurchase$1,001 - $15,000+65.3%S&P +142.6% · vs S&P 500 -77.3%Jul 9, 2020Aug 10, 202032d
Josh GottheimerJointStockPurchase$1,001 - $15,000+125.5%S&P +207.4% · vs S&P 500 -81.9%Apr 3, 2020May 13, 202040d

Since the trade: the stock's move from the trade date to the latest close we hold, as of Sep 10, 2026, an estimate, with the S&P 500 over the same window and the difference against it. The figures describe the stock after the trade, not the member's result: the filing carries a band, not a fill, and a sale keeps the same sign, so a positive figure after a sale means the stock kept rising. An option row carries the underlying stock's move. A row marked n/a has no market price. Not investment advice.

Members of Congress reporting a position

2 members · estimate, as of Sep 10, 2026

2 members report a position (estimated). The largest estimated position is in the $15,001 - $50,000 band.

MemberParty, chamberEstimated positionShare of their portfolio
Gilbert Ray Cisneros, Jr.Democrat · House$15,001 - $50,0000.1%
Josh GottheimerDemocrat · House$1,001 - $15,000<0.1%

Estimate, as of Sep 10, 2026. Each position is modelled from the member's disclosed transactions and annual filings: the midpoint of each disclosed band, moved with the stock's price since the trade. It is a rough estimate of a reported position, not a figure from a filing, which is why it is shown as a band. Share of portfolio sets that estimate against the member's whole estimated public-stock portfolio.

Questions

Which members of Congress have traded HQY?

Gilbert Ray Cisneros, Jr., Lisa C. McClain, Robert Bresnahan, Josh Gottheimer, Blake D. Moore, Daniel S. Goldman disclosed HQY transactions in the filings shown here.

Which members of Congress hold HQY?

2 members of Congress report a position in HQY in the estimate we hold as of Sep 10, 2026. The two largest estimated positions belong to Gilbert Ray Cisneros, Jr. and Josh Gottheimer. The estimate is built from disclosed transactions and annual filings, so it is shown as a band rather than a figure from a filing.

How quickly are HQY trades disclosed?

Congressional disclosures took a median of 39 days, against the 45 the STOCK Act allows.

How to read a STOCK Act filing

WHAT THE FILING ACTUALLY SAYS

$A range, not an amount. Members disclose a band such as $1,001 to $15,000. The band is the filing, and we do not narrow it.
45Up to 45 days late, lawfully. The delay column counts calendar days from the transaction to its publication. Inside 45 days is within the law.
OPAn option names the underlying. A contract on a company is described using that company's name, so it can read like a share purchase. Those rows say otherwise.

Congress rows disclose a value range rather than an exact amount, and the STOCK Act allows up to 45 days to report. Full sourcing and the limits of this data are on the methodology page. A filing is a record of a transaction, not a signal, and nothing here is investment advice.

Data as of Sep 10, 2026.

Related companies

traded by the same members

See every company we track